BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15218188)

  • 1. Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted 'epitope-loss variant'.
    Lin JC; Cherng JM; Lin HJ; Tsang CW; Liu YX; Lee SP
    J Gen Virol; 2004 Jul; 85(Pt 7):2023-2034. PubMed ID: 15218188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.
    Lin HJ; Cherng JM; Hung MS; Sayion Y; Lin JC
    J Biomed Sci; 2005 Dec; 12(6):925-36. PubMed ID: 16307312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence variation in the Epstein-Barr virus latent membrane protein 1.
    Miller WE; Edwards RH; Walling DM; Raab-Traub N
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2729-40. PubMed ID: 7931159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes.
    Tang YL; Lu JH; Cao L; Wu MH; Peng SP; Zhou HD; Huang C; Yang YX; Zhou YH; Chen Q; Li XL; Zhou M; Li GY
    Braz J Med Biol Res; 2008 Feb; 41(2):110-6. PubMed ID: 18297191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China.
    Sung NS; Edwards RH; Seillier-Moiseiwitsch F; Perkins AG; Zeng Y; Raab-Traub N
    Int J Cancer; 1998 Apr; 76(2):207-15. PubMed ID: 9537582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia.
    See HS; Yap YY; Yip WK; Seow HF
    World J Surg Oncol; 2008 Feb; 6():18. PubMed ID: 18275617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of an Epstein-Barr-virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population.
    Chang YS; Su IJ; Chung PJ; Shu CH; Ng CK; Wu SJ; Liu ST
    Int J Cancer; 1995 Sep; 62(6):673-7. PubMed ID: 7558413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.
    Jen KY; Higuchi M; Cheng J; Li J; Wu LY; Li YF; Lin HL; Chen Z; Gurtsevitch V; Fujii M; Saku T
    Virus Genes; 2005 Mar; 30(2):223-35. PubMed ID: 15744579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the Taiwan variant of the Epstein-Barr virus in nasopharyngeal carcinoma patients and normal individuals.
    Shu CH; Tu TY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):288-93. PubMed ID: 10820907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
    Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
    J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.
    Chen ML; Tsai CN; Liang CL; Shu CH; Huang CR; Sulitzeanu D; Liu ST; Chang YS
    Oncogene; 1992 Nov; 7(11):2131-40. PubMed ID: 1331932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of Epstein-Barr virus with BamHI "f" variant and XhoI-loss of LMP1 gene in nasopharyngeal carcinoma].
    Han AJ; Zong YS; Zhang M; Cao SM; Lin SX; Liang YJ
    Zhonghua Bing Li Xue Za Zhi; 2003 Dec; 32(6):534-8. PubMed ID: 14761599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.
    Lee SP; Thomas WA; Murray RJ; Khanim F; Kaur S; Young LS; Rowe M; Kurilla M; Rickinson AB
    J Virol; 1993 Dec; 67(12):7428-35. PubMed ID: 7693972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
    Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sequence analysis of the CTL epitopes in transmembrane region of latent membrane protein 2 of Epstein-Barr virus derived from nasopharyngeal carcinoma cells].
    Zhang NH; Zhang XS; Li J; Zhang RH; Gao YF; Zeng MS
    Ai Zheng; 2006 May; 25(5):566-9. PubMed ID: 16687075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines.
    Chen MR; Tsai CH; Wu FF; Kan SH; Yang CS; Chen JY
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():447-455. PubMed ID: 10073707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Internal deletions of the latent membrane protein oncogenes of Epstein-Barr virus in Hodgkin's disease are almost identical with those of Asiatic nasopharyngeal carcinoma].
    Odermatt BF; Heitz PU; Bachmann E; Brousset P; Sandvej K; Knecht H
    Verh Dtsch Ges Pathol; 1994; 78():324-8. PubMed ID: 7534006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of latent membrane protein-1 30-bp deletion variant with specific single mutations in Epstein-Barr virus-associated nasopharyngeal carcinoma in Moroccan patients.
    Dardari R; Khyatti M; Cordeiro P; Odda M; ElGueddari B; Hassar M; Menezes J
    Int J Cancer; 2006 Apr; 118(8):1977-83. PubMed ID: 16287066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.
    Cheung ST; Leung SF; Lo KW; Chiu KW; Tam JS; Fok TF; Johnson PJ; Lee JC; Huang DP
    Int J Cancer; 1998 May; 76(3):399-406. PubMed ID: 9579578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma.
    Duraiswamy J; Sherritt M; Thomson S; Tellam J; Cooper L; Connolly G; Bharadwaj M; Khanna R
    Blood; 2003 Apr; 101(8):3150-6. PubMed ID: 12468425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.